187 related articles for article (PubMed ID: 36351644)
21. Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy.
Jayachandran PK; Rajan AK; Karunakaran P; Mehra N; Selvarajan G; Kesana S; Dhanushkodi M; Radhakrishnan V; Sagar TG
Leuk Res; 2020 Aug; 95():106391. PubMed ID: 32559556
[TBL] [Abstract][Full Text] [Related]
22. Extraoral plasmablastic lymphomas in a high human immunodeficiency virus endemic area.
Meer S; Perner Y; McAlpine ED; Willem P
Histopathology; 2020 Jan; 76(2):212-221. PubMed ID: 31361906
[TBL] [Abstract][Full Text] [Related]
23. Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Atallah-Yunes SA; Murphy D; Abdelmalak R; Mantle L; Ali SS
Eur J Haematol; 2019 Dec; 103(6):620-622. PubMed ID: 31505061
[TBL] [Abstract][Full Text] [Related]
24. Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and Lenalidomide.
Cheng L; Song Q; Liu M; Wang Y; Yi H; Qian Y; Xu P; Cheng S; Wang C; Wang L; Zhao W
Front Immunol; 2021; 12():702593. PubMed ID: 34322131
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].
Han X; Hu LX; Ouyang MQ; Duan MH; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2017 Apr; 38(4):290-294. PubMed ID: 28468089
[No Abstract] [Full Text] [Related]
26. Follicular lymphoma suggested to transform into EBV-negative plasmablastic lymphoma.
Yamada T; Hara T; Goto N; Iwata H; Tsurumi H
Int J Hematol; 2019 Jun; 109(6):723-730. PubMed ID: 30859398
[TBL] [Abstract][Full Text] [Related]
27. Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysis.
Dittus C; Grover N; Ellsworth S; Tan X; Park SI
Leuk Lymphoma; 2018 Sep; 59(9):2121-2127. PubMed ID: 29303024
[TBL] [Abstract][Full Text] [Related]
28. Orbital Plasmablastic Lymphoma: A Rare Variant of Diffuse Large B-Cell Lymphoma Staged and Followed Up by 18F-FDG PET/CT.
Bansal H; Ravina M; Chandrakar PK; Lukose TT; Krishna S
Clin Nucl Med; 2022 Jan; 47(1):e37-e38. PubMed ID: 34269735
[TBL] [Abstract][Full Text] [Related]
29. Oral plasmablastic lymphoma: A case report.
Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
[TBL] [Abstract][Full Text] [Related]
30. An Atypical Presentation of an Uncommon Malignancy: Plasmablastic Lymphoma Presenting As Recurrent Scrotal Abscesses.
Wiemer L; Quan JR; Omman R
Cureus; 2023 May; 15(5):e38879. PubMed ID: 37303424
[TBL] [Abstract][Full Text] [Related]
31. HIV-related plasmablastic lymphoma causing extensive bone destruction in the mandible.
Kayahara GM; Valente VB; Salzedas LMP; Passador-Santos F; Furuse C; Biasoli ÉR; Miyahara GI; Bernabé DG
Oral Oncol; 2022 Mar; 126():105761. PubMed ID: 35151011
[TBL] [Abstract][Full Text] [Related]
32. Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management.
Ramirez-Gamero A; Martínez-Cordero H; Beltrán BE; Florindez J; Malpica L; Castillo JJ
Am J Hematol; 2024 May; ():. PubMed ID: 38767403
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and survival analysis of 15 cases of HIV-negative plasmablastic lymphoma].
Fu WJ; He MX; Huang AJ; Gao L; Lu GH; Chen J; Chen L; Ni X; Zhang WP; Wang JM; Yang JM
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):456-461. PubMed ID: 32654457
[No Abstract] [Full Text] [Related]
34. [HIV-negative plasmablastic lymphoma sustaining long-term response after autologous peripheral blood stem cell transplantation].
Kitagawa T; Onaka T; Yonezawa A
Rinsho Ketsueki; 2022; 63(3):201-205. PubMed ID: 35387933
[TBL] [Abstract][Full Text] [Related]
35. [Plasmablastic lymphoma].
Fernández-Álvarez R; Sancho JM; Ribera JM
Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
[TBL] [Abstract][Full Text] [Related]
36. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic characteristics of HIV/AIDS-related plasmablastic lymphoma.
Wang D; Zheng Y; Zeng D; Yang Y; Zhang X; Feng Y; Lu H
Int J STD AIDS; 2017 Mar; 28(4):380-388. PubMed ID: 27164966
[TBL] [Abstract][Full Text] [Related]
38. Post-treatment positron emission tomography-computed tomography is highly predictive of outcome in Plasmablastic lymphoma.
Al Tabaa Y; Tchernonog E; Faurie P; Cottereau AS; Monjanel H; Bonnet A; Le Gouill S; Gyan E; Ghesquieres H; Mariano-Goulart D; Cartron G
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1705-1709. PubMed ID: 29679112
[TBL] [Abstract][Full Text] [Related]
39. Plasmablastic lymphoma may occur as a high-grade transformation from plasmacytoma.
Qing X; Sun N; Chang E; French S; Ji P; Yue C
Exp Mol Pathol; 2011 Feb; 90(1):85-90. PubMed ID: 20969860
[TBL] [Abstract][Full Text] [Related]
40. A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy.
Schmit JM; DeLaune J; Norkin M; Grosbach A
Oncol Res Treat; 2017; 40(1-2):46-48. PubMed ID: 28095384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]